These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 31875307)

  • 1. Preclinical evaluation of binimetinib (MEK162) delivered via polymeric nanocarriers in combination with radiation and temozolomide in glioma.
    Bikhezar F; de Kruijff RM; van der Meer AJGM; Torrelo Villa G; van der Pol SMA; Becerril Aragon G; Gasol Garcia A; Narayan RS; de Vries HE; Slotman BJ; Denkova AG; Sminia P
    J Neurooncol; 2020 Jan; 146(2):239-246. PubMed ID: 31875307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The allosteric AKT inhibitor MK2206 shows a synergistic interaction with chemotherapy and radiotherapy in glioblastoma spheroid cultures.
    Narayan RS; Fedrigo CA; Brands E; Dik R; Stalpers LJ; Baumert BG; Slotman BJ; Westerman BA; Peters GJ; Sminia P
    BMC Cancer; 2017 Mar; 17(1):204. PubMed ID: 28320338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of MEK162 as a Radiosensitizer for the Treatment of Glioblastoma.
    Narayan RS; Gasol A; Slangen PLG; Cornelissen FMG; Lagerweij T; Veldman HYYE; Dik R; van den Berg J; Slotman BJ; Würdinger T; Haas-Kogan DA; Stalpers LJA; Baumert BG; Westerman BA; Theys J; Sminia P
    Mol Cancer Ther; 2018 Feb; 17(2):347-354. PubMed ID: 28958992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inhibition of proliferation and migration of glioma spheroids exposed to temozolomide is less than additive if combined with irradiation.
    Fehlauer F; Muench M; Richter E; Rades D
    Oncol Rep; 2007 Apr; 17(4):941-5. PubMed ID: 17342340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of transferrin-modified poly(lactic-co-glycolic acid) nanoparticles for glioma therapy.
    Mao J; Meng X; Zhao C; Yang Y; Liu G
    Anticancer Drugs; 2019 Jul; 30(6):604-610. PubMed ID: 30855310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cordycepin Augments the Chemosensitivity of Human Glioma Cells to Temozolomide by Activating AMPK and Inhibiting the AKT Signaling Pathway.
    Bi Y; Li H; Yi D; Sun Y; Bai Y; Zhong S; Song Y; Zhao G; Chen Y
    Mol Pharm; 2018 Nov; 15(11):4912-4925. PubMed ID: 30336060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overcoming the Blood-Brain Tumor Barrier with Docetaxel-Loaded Mesoporous Silica Nanoparticles for Treatment of Temozolomide-Resistant Glioblastoma.
    Hsu TI; Chen YP; Zhang RL; Chen ZA; Wu CH; Chang WC; Mou CY; Chan HW; Wu SH
    ACS Appl Mater Interfaces; 2024 May; 16(17):21722-21735. PubMed ID: 38629735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mild thermotherapy and hyperbaric oxygen enhance sensitivity of TMZ/PSi nanoparticles via decreasing the stemness in glioma.
    Zeng X; Wang Q; Tan X; Jia L; Li Y; Hu M; Zhang Z; Bai X; Zhu Y; Yang X
    J Nanobiotechnology; 2019 Apr; 17(1):47. PubMed ID: 30935403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The therapeutic potential of polymersomes loaded with
    de Kruijff RM; van der Meer AJGM; Windmeijer CAA; Kouwenberg JJM; Morgenstern A; Bruchertseifer F; Sminia P; Denkova AG
    Eur J Pharm Biopharm; 2018 Jun; 127():85-91. PubMed ID: 29428791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiopep-2-Functionalized Lipid Cubosomes for Blood-Brain Barrier Crossing and Glioblastoma Treatment.
    Cai X; Refaat A; Gan PY; Fan B; Yu H; Thang SH; Drummond CJ; Voelcker NH; Tran N; Zhai J
    ACS Appl Mater Interfaces; 2024 Mar; 16(10):12161-12174. PubMed ID: 38416873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-catenin contributes to cordycepin-induced MGMT inhibition and reduction of temozolomide resistance in glioma cells by increasing intracellular reactive oxygen species.
    Bi Y; Li H; Yi D; Bai Y; Zhong S; Liu Q; Chen Y; Zhao G
    Cancer Lett; 2018 Oct; 435():66-79. PubMed ID: 30081068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming blood brain barrier with a dual purpose Temozolomide loaded Lactoferrin nanoparticles for combating glioma (SERP-17-12433).
    Kumari S; Ahsan SM; Kumar JM; Kondapi AK; Rao NM
    Sci Rep; 2017 Jul; 7(1):6602. PubMed ID: 28747713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic Suppression of Glioblastoma Cell Growth by Combined Application of Temozolomide and Dopamine D2 Receptor Antagonists.
    Liu Z; Jiang X; Gao L; Liu X; Li J; Huang X; Zeng T
    World Neurosurg; 2019 Aug; 128():e468-e477. PubMed ID: 31048057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemosensitization of Temozolomide-Resistant Pediatric Diffuse Midline Glioma Using Potent Nanoencapsulated Forms of a N(3)-Propargyl Analogue.
    Heravi Shargh V; Luckett J; Bouzinab K; Paisey S; Turyanska L; Singleton WGB; Lowis S; Gershkovich P; Bradshaw TD; Stevens MFG; Bienemann A; Coyle B
    ACS Appl Mater Interfaces; 2021 Aug; 13(30):35266-35280. PubMed ID: 34310112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing the efficacy of drug-loaded nanocarriers against brain tumors by targeted radiation therapy.
    Baumann BC; Kao GD; Mahmud A; Harada T; Swift J; Chapman C; Xu X; Discher DE; Dorsey JF
    Oncotarget; 2013 Jan; 4(1):64-79. PubMed ID: 23296073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study on Therapeutic Action and Mechanism of TMZ Combined with RITA Against Glioblastoma.
    Wu Q; Cao Z; Xiao W; Zhu L; Xie Q; Li L; Zhang B; Zhao W
    Cell Physiol Biochem; 2018; 51(6):2536-2546. PubMed ID: 30562758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
    Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
    Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temozolomide Efficacy and Metabolism: The Implicit Relevance of Nanoscale Delivery Systems.
    Petrenko D; Chubarev V; Syzrantsev N; Ismail N; Merkulov V; Sologova S; Grigorevskikh E; Smolyarchuk E; Alyautdin R
    Molecules; 2022 May; 27(11):. PubMed ID: 35684445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of the effects of a sphingosine kinase inhibitor to temozolomide and radiation treatment on glioblastoma cell lines.
    Oancea-Castillo LR; Klein C; Abdollahi A; Weber KJ; Régnier-Vigouroux A; Dokic I
    Cancer Biol Ther; 2017 Jun; 18(6):400-406. PubMed ID: 28494176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focused ultrasound-induced blood-brain barrier opening to enhance temozolomide delivery for glioblastoma treatment: a preclinical study.
    Wei KC; Chu PC; Wang HY; Huang CY; Chen PY; Tsai HC; Lu YJ; Lee PY; Tseng IC; Feng LY; Hsu PW; Yen TC; Liu HL
    PLoS One; 2013; 8(3):e58995. PubMed ID: 23527068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.